The treatment success rate for HIV-positive tuberculosis in Canada has shown a consistent upward trend in the forecasted data. Starting from 2023, where the rate stood at 89%, there is a notable year-on-year improvement in 2024 to 90%, followed by incremental increases reaching 93% by 2028. The year-on-year variation from 2024 to 2028 shows steady growth, with the compound annual growth rate (CAGR) averaging out to a smooth progression over these years.

Future trends to watch for include:

Advancements in medical treatments and technologies that could further enhance the success rates beyond current forecasts.
Government and healthcare policy changes focusing on integrated care for HIV and tuberculosis co-infections may impact the forecast.
Global health initiatives and funding aimed at combating tuberculosis and HIV, potentially accelerating success rates.